148777-84-8

Basic information

• Product Name: 3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyriMidine
• Synonyms: 3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyriMidine;3-nitro-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine;3-Nitro-4,5,6,7-tetrahydropyr
• CAS NO: 148777-84-8
• Molecular Formula: C6H8N4O2
• Molecular Weight: 168.15332
• Mol File: 148777-84-8.mol

Chemical Properties

• Boiling Point: 383.7±30.0 °C(Predicted)
• Appearance: /
• Density: 1.72±0.1 g/cm3(Predicted)
• PKA: 0.19±0.20(Predicted)
• CAS DataBase Reference: 3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyriMidine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyriMidine(148777-84-8)
• EPA Substance Registry System: 3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyriMidine(148777-84-8)

Safety Data

• Hazardous Substances Data: 148777-84-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine is used as a diuretic and antihypertensive agent for its potential to treat high blood pressure and promote the removal of excess fluid from the body.
Used in Cardiovascular Disease Treatment:
3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine is used as a potential treatment for cardiovascular diseases due to its potential to improve heart health and reduce the risk of heart-related complications.
Used in Antitubercular Therapy:
3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine is used as a potential antitubercular agent for its potential to treat tuberculosis, a bacterial infection that primarily affects the lungs.
Further studies are needed to fully elucidate the biological activities and potential therapeutic applications of 3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine.

Upstream product

• 126352-69-0 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine 
• 126352-82-7 4-formyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine 
• 16115-82-5 4-nitro-1H-pyrazol-3-amine 
• 109-64-8 1,3-dibromo-propane 

Relevant articles and documents

CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS

The present invention provides a compound of the formula [I]: wherein R1 is lower alkyl, etc. and R2 is hydrogen, etc., or R1 and R2 are bonded together to form lower alkylene; R3 is a group represented by wherein R6 and R7 are independently optionally pr

CEPHEM COMPOUNDS

The present invention relates to a compound of the formula [I]: wherein R1 is lower alkyl, hydroxy(lower)alkyl or halo(lower)alkyl, and R2 is hydrogen or amino protecting group, or R1 and R2 are bonded together and form lower alkylene or lower alkenylene; R3 is hydrogen or lower alkyl; R4 is ; R5 is carboxy or protected carboxy; and R6 is amino or protected amino, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier.

Hair dye containing aminopyrazole derivatives as well as pyrazole derivatives

The composition for oxidative dyeing of hair contains at least one coupler and 0.010 to 3.0 percent by weight of at least one developer selected from the group consisting of aminopyrazole derivatives of the formula (I): STR1 wherein R is selected from the group consisting of hydrogen and alkyl groups having one to four carbon atoms; n=2 or 3; and physiologically tolerated, water-soluble salts thereof. The developer and coupler substances are present in the composition in a total amount of from 0.1 to 5.0 percent. New pyrazole derivative compounds are also part of the invention.